164 related articles for article (PubMed ID: 11435723)
1. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Di Sebastiano P; di Mola FF; Artese L; Rossi C; Mascetta G; Pernthaler H; Innocenti P
Digestion; 2001; 63(4):234-9. PubMed ID: 11435723
[TBL] [Abstract][Full Text] [Related]
2. Influence of the matrix metalloproteinase inhibitor batimastat (BB-94) on periodontal bone destruction in Sprague-Dawley rats.
Björnsson MJ; Havemose-Poulsen A; Stoltze K; Holmstrup P
J Periodontal Res; 2004 Aug; 39(4):269-74. PubMed ID: 15206921
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
Wang YD; Wang W
World J Gastroenterol; 2008 Oct; 14(37):5683-8. PubMed ID: 18837084
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis.
Muhs BE; Patel S; Yee H; Marcus S; Shamamian P
J Surg Res; 2003 Feb; 109(2):110-7. PubMed ID: 12643851
[TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR
J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797
[TBL] [Abstract][Full Text] [Related]
6. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis.
Di Sebastiano P; Grossi L; Di Mola FF; Angelucci D; Friess H; Marzio L; Innocenti P; Büchler MW
Dig Dis Sci; 1999 Feb; 44(2):439-44. PubMed ID: 10063935
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
Kullmann F; Arndt H; Gross V; Rüschoff J; Schölmerich J
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
[TBL] [Abstract][Full Text] [Related]
8. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis.
Rachmilewitz D; Karmeli F; Okon E; Rubenstein I; Better OS
Gut; 1998 Oct; 43(4):512-8. PubMed ID: 9824579
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
10. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease.
Sykes AP; Bhogal R; Brampton C; Chander C; Whelan C; Parsons ME; Bird J
Aliment Pharmacol Ther; 1999 Nov; 13(11):1535-42. PubMed ID: 10571613
[TBL] [Abstract][Full Text] [Related]
11. Role of P-selectin and intercellular adhesion molecule-1 in TNB-induced colitis in rats.
Yoshida N; Yamaguchi T; Nakagawa S; Nakamura Y; Naito Y; Yoshikawa T
Digestion; 2001; 63 Suppl 1():81-6. PubMed ID: 11173915
[TBL] [Abstract][Full Text] [Related]
12. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
Rachmilewitz D; Karmeli F; Okon E; Bursztyn M
Gut; 1995 Aug; 37(2):247-55. PubMed ID: 7557576
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
[TBL] [Abstract][Full Text] [Related]
14. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats.
Qiu BS; Pfeiffer CJ; Keith JC
Dig Dis Sci; 1996 Aug; 41(8):1625-30. PubMed ID: 8769290
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis.
Gul Utku O; Akbay Karatay E; Erdal H; Arhan M; Onal IK; Ibis M; Ekinci O; Yilmaz Demirtas C; Unal S
Med Princ Pract; 2015; 24(5):470-6. PubMed ID: 26111863
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators of experimental colitis in rats.
Rachmilewitz D; Simon PL; Schwartz LW; Griswold DE; Fondacaro JD; Wasserman MA
Gastroenterology; 1989 Aug; 97(2):326-37. PubMed ID: 2545504
[TBL] [Abstract][Full Text] [Related]
18. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
Nosoudi N; Nahar-Gohad P; Sinha A; Chowdhury A; Gerard P; Carsten CG; Gray BH; Vyavahare NR
Circ Res; 2015 Nov; 117(11):e80-9. PubMed ID: 26443597
[TBL] [Abstract][Full Text] [Related]
19. Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis.
Oren R; Maaravi Y; Karmeli F; Kenet G; Zeidel L; Hubert A; Eliakim R
Aliment Pharmacol Ther; 1997 Apr; 11(2):341-5. PubMed ID: 9146773
[TBL] [Abstract][Full Text] [Related]
20. The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat.
de Hingh IH; Siemonsma MA; de Man BM; Lomme RM; Hendriks T
Int J Colorectal Dis; 2002 Sep; 17(5):348-54. PubMed ID: 12172929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
